...
机译:抗CD44 mAb用于治疗B细胞慢性淋巴细胞性白血病和其他血液系统恶性肿瘤:WO2013063498的评估
IRCCS 'Centra di Riferimento Oncologico della Basilicata', Hematology Oncology Department, 85028 Rionero in Vulture, Italy;
IRCCS 'Centra di Riferimento Oncologico della Basilicata', Hematology Oncology Department, 85028 Rionero in Vulture, Italy,University of Messina, Department of Clinical and Experimental Medicine, Messina, Italy;
IRCCS 'Centra di Riferimento Oncologico della Basilicata', Hematology Oncology Department, 85028 Rionero in Vulture, Italy,University of Turin, Department of Medical Sciences, Turin, Italy,Human Genetics Foundation (HuGeF), Turin,Italy;
CD44; chronic lymphocytic leukemia; mAbs; targeted therapies;
机译:威尼柯克斯:一种新型B细胞淋巴瘤-2慢性淋巴细胞白血病和其他血液学恶性肿瘤抑制剂
机译:实时分析mAb介导的B细胞系和慢性淋巴细胞性白血病B细胞的补体依赖性细胞毒性中细胞事件的详细序列
机译:伊达拉西布治疗惰性B细胞恶性肿瘤:慢性淋巴细胞性白血病和小淋巴细胞或滤泡性淋巴瘤
机译:B细胞慢性淋巴细胞白血病术术模型的全局敏感性分析
机译:Omega-3脂肪酸可作为治疗B细胞慢性淋巴细胞性白血病的治疗选择。
机译:伊达拉西布治疗惰性B细胞恶性肿瘤:慢性淋巴细胞白血病和小淋巴细胞或滤泡性淋巴瘤
机译:小鼠的EBI2过表达导致B1 B细胞膨胀和慢性淋巴细胞白血病样B细胞恶性肿瘤